UCB0942

· UCB Biopharma S.P.R.L.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for UCB0942, covering 2017-08-22 to 2022-01-31. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy [Phase 2]